Open AccessWHO consolidated guidelines on tuberculosis 2020 moving toward fully oral regimen: Should country act in hurry?
Author(s) -
Nirmal Jain
Publication year - 2021
Publication title -
lung india
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 25
eISSN - 0974-598X
pISSN - 0970-2113
DOI - 10.4103/lungindia.lungindia_982_20
Subject(s) - bedaquiline , medicine , clofazimine , regimen , tuberculosis , rifampicin , linezolid , intensive care medicine , adverse effect , expanded access , extensively drug resistant tuberculosis , isoniazid , mycobacterium tuberculosis , leprosy , pathology , vancomycin , biology , bacteria , genetics , staphylococcus aureus